In this podcast, Jennifer Curtis and David Jackson share valuable insights on global commercial excellence. They highlight strategies to optimize product launches and maximize revenue potential, based on recent research conducted by ZS on the t...

Jennifer Curtis, Pranav Srivastava and Surbhi Puri discuss customer experience in cell and gene therapy (CGT), drawing on recent ZS patient experience study outcomes.

Innovation is far more diffuse today, reflecting the increasingly fragmented nature of the pharma industry. On top of that, late-stage deals significantly underperform compared to early-stage strategy. So pharma may be in line for a shift in st...

On this episode of Inside Global Pharma, Jennifer Curtis and Maria Whitman discuss trends in global launches—from ...

In this edition of the IGP podcast, Jennifer Curtis connects with Josh Hattem to discuss trends in oncology portfolio strategy, buil...

Jennifer Curtis connects with Ben Hohn to discuss trends in first launch and partnering, focusing on emerging pharma and changes in strategic decision-making.Highlights from the episode include:·       ...

In this edition,

Jennifer Curtis and Jeffrey Moore discuss recent ZS insights and trends in #customerengagement.

The road to commercializing cell and gene therapies has been long, with many highs and lows along the way. However, the last few years have seen strong market growth and a very crowded pipeline. In this episode, ZS’s Jennifer Curtis and Sankalp...